デフォルト表紙
市場調査レポート
商品コード
1301029

細胞凍結培地の市場規模、シェア、動向分析レポート:製品別、用途別、最終用途別、地域別、セグメント予測、2023年~2030年

Cell Freezing Media Market Size, Share & Trends Analysis Report By Product (DMSO, Glycerol), By Application (Stem Cell Lines, Cancer Cell Lines), By End-use, By Region, And Segment Forecasts, 2023 - 2030


出版日
ページ情報
英文 150 Pages
納期
2~10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
細胞凍結培地の市場規模、シェア、動向分析レポート:製品別、用途別、最終用途別、地域別、セグメント予測、2023年~2030年
出版日: 2023年06月13日
発行: Grand View Research
ページ情報: 英文 150 Pages
納期: 2~10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

細胞凍結培地市場の成長と動向

GrandView Research社の最新レポートによると、世界の細胞凍結培地市場規模は2030年までに2億9,130万米ドルに達する見込みです。

2023年から2030年にかけてのCAGRは9.62%に達すると推定され、これは、すぐに凍結できる培地の採用が増加していることと、バイオ医薬品のパイプラインが増加し、これらの製品の需要が高まっていることが背景にあります。加えて、慢性疾患の有病率の増加や、その管理における細胞治療の重要性の高まりが、効果的な細胞凍結培地の牽引力となっています。

先進的な治療法を開発するための研究開発活動が活発化しているため、費用対効果の高い凍結保存培地に対する需要が高まっています。生細胞を凍結保存している間に氷の結晶形成を抑えることができる即使用可能な培地は、最終的に研究コミュニティでの採用増加につながっています。さらに、安全性と有効性の向上によるバイオ医薬品の人気の高まりは、生命を脅かす疾患のための先進的なバイオ医薬品を開発するために、メーカーから莫大な投資を呼び起こしました。

COVID-19ワクチンの急速な研究開発とその継続的な商業生産活動も、生物製剤に基づく研究活動にプラスの影響を与え、またそれを後押しし、最終的に市場の成長を押し上げました。市場需要の増加、競合企業間の競争激化、エンドユーザーによる様々な用途も、細胞凍結培地の処方の進歩に起因しており、現在ではカスタムメイドの要求に応じて入手することも可能です。例えば、Merck KGaAのSigma Aldrichブランドは、幹細胞アプリケーション用の凍結培地ソリューションを提供しており、最適な回収と細胞の生存を実現しています。

細胞治療研究の急速な進展と、様々な疾患における細胞治療の採用拡大が、世界市場に旺盛な需要を生み出しています。細胞凍結培地は、細胞治療アプリケーションに不可欠な解凍・凍結プロセスにおいて、細胞の機能性を維持する上で非常に重要な役割を担っています。加えて、慢性疾患の管理における細胞療法の応用を強化するために市場参入企業が行っている様々な戦略が、市場拡大を加速すると予測されています。例えば、2022年9月、Scribe TherapeuticsとSanofiは、CRISPRをベースとしたがんの治療法を商業化するための提携を発表しました。

細胞凍結培地市場レポートハイライト

  • DMSO(ジメチルスルホキシド)セグメントは2022年の売上高シェア51.46%で市場を独占しており、これは細胞の代謝活動を停止させるために従来の凍結保存でDMSOを長年使用してきたことからゴールドスタンダードが確立されたことに起因しています。
  • 幹細胞ラインが細胞凍結培地の最大の用途であるのに対し、がん細胞ラインは細胞・遺伝子治療製品の臨床成功率の増加により急成長が見込まれます。
  • エンドユースセグメント全体では、製薬・バイオテクノロジー企業セグメントが2022年の収益シェア42.42%で市場を独占しました。この高い収益成長は、バイオ医薬品の継続的な成長と商業的成功に加え、大手製薬企業のポートフォリオの拡大別ものです。
  • 北米地域は2022年に世界市場を独占したが、これはバイオ医薬品のパイプラインが拡大していること、主要企業が多数存在すること、細胞凍結培地の需要が高まっていること、新興経済諸国とともに医療インフラが発達していること別。

目次

第1章 調査手法と範囲

  • 情報調達
  • 情報またはデータ分析
  • 市場範囲とセグメントの定義
  • 市場モデル

第2章 エグゼクティブサマリー

  • 市場スナップショット
  • セグメントのスナップショット
  • 競合情勢のスナップショット

第3章 市場変数、動向、および範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/補助的な市場見通し
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 業界分析ツール
    • ポーターのファイブフォース分析
    • PESTEL分析
    • COVID-19感染症の影響分析

第4章 製品のビジネス分析

  • 細胞凍結培地市場:製品変動分析
  • DMSO
    • DMSO市場、2018年~2030年
    • DMSOと血清
    • 無血清DMSO
  • グリセロール
    • グリセロール市場、2018-2030
    • グリセロールと血清
    • 無血清グリセロール
  • その他
    • その他市場、2018-2030

第5章 用途のビジネス分析

  • 細胞凍結培地市場:用途変動分析
  • 幹細胞株
  • がん細胞株
  • その他

第6章 最終用途のビジネス分析

  • 細胞凍結培地市場:最終用途の変動分析
  • 製薬およびバイオテクノロジー企業
  • 学術研究機関
  • その他

第7章 地域のビジネス分析

  • 地域別の細胞凍結培地市場シェア、2022年および2030年
  • 北米
    • SWOT分析
    • 北米の細胞凍結培地市場、2018年~2030年
    • 米国
    • カナダ
  • 欧州
    • SWOT分析
    • 欧州の細胞凍結培地市場、2018年~2030年
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • デンマーク
    • スウェーデン
    • ノルウェー
  • アジア太平洋地域
    • SWOT分析
    • アジア太平洋の細胞凍結培地市場、2018年~2030年
    • 日本
    • 中国
    • インド
    • オーストラリア
    • タイ
    • 韓国
  • ラテンアメリカ
    • SWOT分析
    • ラテンアメリカの細胞凍結培地市場、2018年~2030年
    • ブラジル
    • メキシコ
    • アルゼンチン
  • MEA
    • SWOT分析
    • MEAの細胞凍結培地市場、2018年~2030年
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第8章 競合情勢

  • 企業の分類
  • 戦略マッピング
  • 企業の市場シェア分析、2022年
  • 企業プロファイル・一覧表
    • Thermo Fisher Scientific, Inc
    • Merck KGaA
    • Sartorius AG
    • Bio-Life Solutions, Inc.
    • Bio-Techne
    • HiMedia Laboratories
    • PromoCell GmbH
    • Capricorn Scientific
    • Cell Applications, Inc.
    • AMSBIO
図表

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Regulatory Framework
  • Table 4 Global Cell Freezing Media Market, By Product, 2018 - 2030 (USD Million)
  • Table 5 Global Cell Freezing Media Market, By Application, 2018 - 2030 (USD Million)
  • Table 6 Global Cell Freezing Media Market, By End use, 2018 - 2030 (USD Million
  • Table 7 Global Cell Freezing Media Market, By Region, 2018 - 2030 (USD Million)
  • Table 8 North America Cell Freezing Media Market, By Country, 2018 - 2030 (USD Million)
  • Table 9 North America Cell Freezing Media Market, By Product, 2018 - 2030 (USD Million)
  • Table 10 North America Cell Freezing Media Market, By Application, 2018 - 2030 (USD Million)
  • Table 11 North America Cell Freezing Media Market, By End Use, 2018 - 2030 (USD Million)
  • Table 12 U.S. Cell Freezing Media Market, By Product, 2018 - 2030 (USD Million)
  • Table 13 U.S. Cell Freezing Media Market, By Application, 2018 - 2030 (USD Million)
  • Table 14 U.S. Cell Freezing Media Market, By End Use, 2018 - 2030 (USD Million)
  • Table 15 Canada Cell Freezing Media Market, By Product, 2018 - 2030 (USD Million)
  • Table 16 Canada Cell Freezing Media Market, By Application, 2018 - 2030 (USD Million)
  • Table 17 Canada Cell Freezing Media Market, By End Use, 2018 - 2030 (USD Million)
  • Table 18 Europe Cell Freezing Media Market, By Country, 2018 - 2030 (USD Million)
  • Table 19 Europe Cell Freezing Media Market, By Application, 2018 - 2030 (USD Million)
  • Table 20 Europe Cell Freezing Media Market, By Product, 2018 - 2030 (USD Million)
  • Table 21 Europe Cell Freezing Media Market, By End Use, 2018 - 2030 (USD Million)
  • Table 22 UK Cell Freezing Media Market, By Product, 2018 - 2030 (USD Million)
  • Table 23 UK Cell Freezing Media Market, By Application, 2018 - 2030 (USD Million)
  • Table 24 UK Cell Freezing Media Market, By End Use, 2018 - 2030 (USD Million)
  • Table 25 Germany Cell Freezing Media Market, By Product, 2018 - 2030 (USD Million)
  • Table 26 Germany Cell Freezing Media Market, By Application, 2018 - 2030 (USD Million)
  • Table 27 Germany Cell Freezing Media Market, By End Use, 2018 - 2030 (USD Million)
  • Table 28 France Cell Freezing Media Market, By Product, 2018 - 2030 (USD Million)
  • Table 29 France Cell Freezing Media Market, By Application, 2018 - 2030 (USD Million)
  • Table 30 France Cell Freezing Media Market, By End Use, 2018 - 2030 (USD Million)
  • Table 31 Spain Cell Freezing Media Market, By Product, 2018 - 2030 (USD Million)
  • Table 32 Spain Cell Freezing Media Market, By Application, 2018 - 2030 (USD Million)
  • Table 33 Spain Cell Freezing Media Market, By End Use, 2018 - 2030 (USD Million)
  • Table 34 Italy Cell Freezing Media Market, By Product, 2018 - 2030 (USD Million)
  • Table 35 Italy Cell Freezing Media Market, By Application, 2018 - 2030 (USD Million)
  • Table 36 Italy Cell Freezing Media Market, By End Use, 2018 - 2030 (USD Million)
  • Table 37 Denmark Cell Freezing Media Market, By Product, 2018 - 2030 (USD Million)
  • Table 38 Denmark Cell Freezing Media Market, By Application, 2018 - 2030 (USD Million)
  • Table 39 Denmark Cell Freezing Media Market, By End Use, 2018 - 2030 (USD Million)
  • Table 40 Norway Cell Freezing Media Market, By Product, 2018 - 2030 (USD Million)
  • Table 41 Norway Cell Freezing Media Market, By Application, 2018 - 2030 (USD Million)
  • Table 42 Norway Cell Freezing Media Market, By End Use, 2018 - 2030 (USD Million)
  • Table 43 Sweden Cell Freezing Media Market, By Product, 2018 - 2030 (USD Million)
  • Table 44 Sweden Cell Freezing Media Market, By Application, 2018 - 2030 (USD Million)
  • Table 45 Sweden Cell Freezing Media Market, By End Use, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific Cell Freezing Media Market, By Country, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific Cell Freezing Media Market, By Product, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific Cell Freezing Media Market, By Application, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific Cell Freezing Media Market, By End Use, 2018 - 2030 (USD Million)
  • Table 50 China Cell Freezing Media Market, By Product, 2018 - 2030 (USD Million)
  • Table 51 China Cell Freezing Media Market, By Application, 2018 - 2030 (USD Million)
  • Table 52 China Cell Freezing Media Market, By End Use, 2018 - 2030 (USD Million)
  • Table 53 Japan Cell Freezing Media Market, By Product, 2018 - 2030 (USD Million)
  • Table 54 Japan Cell Freezing Media Market, By Application, 2018 - 2030 (USD Million)
  • Table 55 Japan Cell Freezing Media Market, By End Use, 2018 - 2030 (USD Million)
  • Table 56 India Cell Freezing Media Market, By Product, 2018 - 2030 (USD Million)
  • Table 57 India Cell Freezing Media Market, By Application, 2018 - 2030 (USD Million)
  • Table 58 India Cell Freezing Media Market, By End Use, 2018 - 2030 (USD Million)
  • Table 59 South Korea Cell Freezing Media Market, By Product, 2018 - 2030 (USD Million)
  • Table 60 South Korea Cell Freezing Media Market, By Application, 2018 - 2030 (USD Million)
  • Table 61 South Korea Cell Freezing Media Market, By End Use, 2018 - 2030 (USD Million)
  • Table 62 Australia Cell Freezing Media Market, By Product, 2018 - 2030 (USD Million)
  • Table 63 Australia Cell Freezing Media Market, By Application, 2018 - 2030 (USD Million)
  • Table 64 Australia Cell Freezing Media Market, By End Use, 2018 - 2030 (USD Million)
  • Table 65 Thailand Cell Freezing Media Market, By Product, 2018 - 2030 (USD Million)
  • Table 66 Thailand Cell Freezing Media Market, By Application, 2018 - 2030 (USD Million)
  • Table 67 Thailand Cell Freezing Media Market, By End Use, 2018 - 2030 (USD Million)
  • Table 68 Latin America Cell Freezing Media Market, By Country, 2018 - 2030 (USD Million)
  • Table 69 Latin America Cell Freezing Media Market, By Product, 2018 - 2030 (USD Million)
  • Table 70 Latin America Cell Freezing Media Market, By Application, 2018 - 2030 (USD Million)
  • Table 71 Latin America Cell Freezing Media Market, By End Use, 2018 - 2030 (USD Million)
  • Table 72 Brazil Cell Freezing Media Market, By Product, 2018 - 2030 (USD Million)
  • Table 73 Brazil Cell Freezing Media Market, By Application, 2018 - 2030 (USD Million)
  • Table 74 Brazil Cell Freezing Media Market, By End Use, 2018 - 2030 (USD Million)
  • Table 75 Mexico Cell Freezing Media Market, By Product, 2018 - 2030 (USD Million)
  • Table 76 Mexico Cell Freezing Media Market, By Application, 2018 - 2030 (USD Million)
  • Table 77 Mexico Cell Freezing Media Market, By End Use, 2018 - 2030 (USD Million)
  • Table 78 Argentina Cell Freezing Media Market, By Product, 2018 - 2030 (USD Million)
  • Table 79 Argentina Cell Freezing Media Market, By Application, 2018 - 2030 (USD Million)
  • Table 80 Argentina Cell Freezing Media Market, By End Use, 2018 - 2030 (USD Million)
  • Table 81 MEA Cell Freezing Media Market, By Country, 2018 - 2030 (USD Million)
  • Table 82 MEA Cell Freezing Media Market, By Product, 2018 - 2030 (USD Million)
  • Table 83 MEA Cell Freezing Media Market, By Application, 2018 - 2030 (USD Million)
  • Table 84 MEA Cell Freezing Media Market, By End Use, 2018 - 2030 (USD Million)
  • Table 85 South Africa Cell Freezing Media Market, By Product, 2018 - 2030 (USD Million)
  • Table 86 South Africa Cell Freezing Media Market, By Application, 2018 - 2030 (USD Million)
  • Table 87 South Africa Cell Freezing Media Market, By End Use, 2018 - 2030 (USD Million)
  • Table 88 UAE Cell Freezing Media Market, By Product, 2018 - 2030 (USD Million)
  • Table 89 UAE Cell Freezing Media Market, By Application, 2018 - 2030 (USD Million)
  • Table 90 UAE Cell Freezing Media Market, By End Use, 2018 - 2030 (USD Million)
  • Table 91 Saudi Arabia Cell Freezing Media Market, By Product, 2018 - 2030 (USD Million)
  • Table 92 Saudi Arabia Cell Freezing Media Market, By Application, 2018 - 2030 (USD Million)
  • Table 93 Saudi Arabia Cell Freezing Media Market, By End Use, 2018 - 2030 (USD Million)
  • Table 94 Kuwait Cell Freezing Media Market, By Product, 2018 - 2030 (USD Million)
  • Table 95 Kuwait Cell Freezing Media Market, By Application, 2018 - 2030 (USD Million)
  • Table 96 Kuwait Cell Freezing Media Market, By End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain - based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 Cell freezing media market segmentation.
  • Fig. 8 Market snapshot, 2022
  • Fig. 9 Market trends & outlook
  • Fig. 10 Market driver relevance analysis (current & future impact)
  • Fig. 11 Market restraint relevance analysis (current & future impact)
  • Fig. 12 PESTEL analysis
  • Fig. 13 Porter's five forces analysis
  • Fig. 14 Global cell freezing media market: Product movement analysis
  • Fig. 15 Global cell freezing media market, for DMSO, 2018 - 2030 (USD Million)
  • Fig. 16 Global cell freezing media market, for DMSO with serum, 2018 - 2030 (USD Million)
  • Fig. 17 Global cell freezing media market, for DMSO without serum, 2018 - 2030 (USD Million)
  • Fig. 18 Global cell freezing media market, for glycerol, 2018 - 2030 (USD Million)
  • Fig. 19 Global cell freezing media market, for glycerol with serum, 2018 - 2030 (USD Million)
  • Fig. 20 Global cell freezing media market, for glycerol without serum, 2018 - 2030 (USD Million)
  • Fig. 21 Global cell freezing media market, for others, 2018 - 2030 (USD Million)
  • Fig. 22 Global cell freezing media market: Application movement analysis
  • Fig. 23 Global cell freezing media market, for stem cell lines, 2018 - 2030 (USD Million)
  • Fig. 24 Global cell freezing media market, for cancer cell lines, 2018 - 2030 (USD Million)
  • Fig. 25 Global cell freezing media market, for others, 2018 - 2030 (USD Million)
  • Fig. 26 Global cell freezing media market: End - use movement analysis
  • Fig. 27 Global cell freezing media market, for academic and research institutes, 2018 - 2030 (USD Million)
  • Fig. 28 Global cell freezing media market, for pharmaceutical & biotechnology companies, 2018 - 2030 (USD Million)
  • Fig. 29 Global cell freezing media market, for others, 2018 - 2030 (USD Million)
  • Fig. 30 Regional marketplace: Key takeaways
  • Fig. 31 Regional outlook, 2022 & 2030
  • Fig. 32 Global cell freezing media market: Region movement analysis
  • Fig. 33 North America cell freezing media market, 2018 - 2030 (USD Million)
  • Fig. 34 U.S. cell freezing media market, 2018 - 2030 (USD Million)
  • Fig. 35 Canada cell freezing media market, 2018 - 2030 (USD Million)
  • Fig. 36 Europe cell freezing media market, 2018 - 2030 (USD Million)
  • Fig. 37 Germany cell freezing media market, 2018 - 2030 (USD Million)
  • Fig. 38 UK cell freezing media market, 2018 - 2030 (USD Million)
  • Fig. 39 France cell freezing media market, 2018 - 2030 (USD Million)
  • Fig. 40 Italy cell freezing media market, 2018 - 2030 (USD Million)
  • Fig. 41 Spain cell freezing media market, 2018 - 2030 (USD Million)
  • Fig. 42 Denmark cell freezing media market, 2018 - 2030 (USD Million)
  • Fig. 43 Sweden cell freezing media market, 2018 - 2030 (USD Million)
  • Fig. 44 Norway cell freezing media market, 2018 - 2030 (USD Million)
  • Fig. 45 Asia Pacific cell freezing media market, 2018 - 2030 (USD Million)
  • Fig. 46 Japan cell freezing media market, 2018 - 2030 (USD Million)
  • Fig. 47 China cell freezing media market, 2018 - 2030 (USD Million)
  • Fig. 48 India cell freezing media market, 2018 - 2030 (USD Million)
  • Fig. 49 Australia cell freezing media market, 2018 - 2030 (USD Million)
  • Fig. 50 South Korea cell freezing media market, 2018 - 2030 (USD Million)
  • Fig. 51 Thailand cell freezing media market, 2018 - 2030 (USD Million)
  • Fig. 52 Latin America cell freezing media market, 2018 - 2030 (USD Million)
  • Fig. 53 Brazil cell freezing media market, 2018 - 2030 (USD Million)
  • Fig. 54 Mexico cell freezing media market, 2018 - 2030 (USD Million)
  • Fig. 55 Argentina cell freezing media market, 2018 - 2030 (USD Million)
  • Fig. 56 Middle East and Africa cell freezing media market, 2018 - 2030 (USD Million)
  • Fig. 57 South Africa cell freezing media market, 2018 - 2030 (USD Million)
  • Fig. 58 Saudi Arabia cell freezing media market, 2018 - 2030 (USD Million)
  • Fig. 59 UAE cell freezing media market, 2018 - 2030 (USD Million)
  • Fig. 60 Kuwait cell freezing media market, 2018 - 2030 (USD Million)
目次
Product Code: GVR-4-68040-087-2

Cell Freezing Media Market Growth & Trends

The global cell freezing media market size is expected to reach USD 291.3 million by 2030, according to a new report by Grand View Research, Inc. It is estimated to register a CAGR of 9.62% from 2023 to 2030, driven by increasing adoption of ready to freezing media, coupled with growing pipeline of biopharmaceuticals leading to a higher demand for these products. In addition, increasing prevalence of chronic disorders, and risen significance of cells therapies in managing them have created traction for effective cell freezing medium.

The growing research and development activities to develop advanced therapies have resulted in increased demand for the cost-effective cryopreservation medium. The ability of ready to use media to reduce the ice crystals formation while cryopreserving viable cells eventually led to its increasing adoption among research community. Furthermore, the increased popularity of biopharmaceuticals due to improved safety and efficacy has cascaded huge investments from manufacturers to develop advanced biopharmaceuticals for life-threatening disorders.

The rapid research and development of COVID-19 vaccine and its continuous commercial production activities has also positively impacted as well as encouraged the biologics-based research activities and eventually boosted the market growth. The increasing market demand, growing competition among players and various application by end users has also attributed to advancements in formulations of cell freezing media and are now even available as per custom requirements. For instance, the Sigma Aldrich brand of Merck KGaA offers freezing media solutions for stem cells application while providing optimal recovery and cells survival.

Rapid advancements in cellular therapy research and growing adoption of cell therapies in various disorders have created a robust demand in the global market. Cell freezing media has a very important role in maintaining functionality of cells during the thawing and freezing process, which is vital for cell therapies applications. In addition, various strategies undertaken by market participants to bolster applications of cellular therapies in managing chronic disorders are projected to accelerate market expansion. For instance, in September 2022, Scribe Therapeutics and Sanofi announced partnership to commercialize CRISPR based therapies for cancer.

Cell Freezing Media Market Report Highlights

  • The DMSO (dimethyl sulfoxide) segment dominated the market in 2022 with a revenue share of 51.46% and is attributed to the established gold standard from years of using DMSO in traditional cryopreservation for suspending the metabolic activities of cells
  • The stem cells lines segment has the largest application of cell freezing media, whereas cancer cell lines expected to witness fastest growth owing to the increasing clinical success rate of cell and gene therapy products
  • Across end use segment, the pharmaceutical and biotechnology companies segment dominated the market with the revenue share of 42.42% in 2022. The higher revenue growth is attributed to the continuous growth and commercial success of biopharmaceuticals coupled with the expanding portfolio of the major pharmaceutical companies
  • North America region dominated the global market in 2022, owing to expanding pipeline for biopharmaceuticals, a large pool of key players, rising demand for cell freezing media, and advanced healthcare infrastructure along with developed economy

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Information Procurement
  • 1.2. Information Or Data Analysis
  • 1.3. Market Scope & Segment Definition
  • 1.4. Market Model
    • 1.4.1. Market Study, By Company Market Share
    • 1.4.2. Regional Analysis

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing demand for cell-based therapies and regenerative medicine
      • 3.2.1.2. Increasing R&D spending by biopharmaceutical and biotechnology companies
      • 3.2.1.3. Advancements in cryopreservation techniques and biopreservation technologies
      • 3.2.1.4. Increasing prevalence of chronic diseases and genetic disorders
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High cost associated with cryopreservation and cell freezing media
      • 3.2.2.2. Stringent regulatory requirements for cell-based products and cryopreservation systems
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Product Business Analysis

  • 4.1. Cell Freezing Media Market: Product Movement Analysis
  • 4.2. DMSO
    • 4.2.1. DMSO Market, 2018 - 2030 (USD Million)
    • 4.2.2. DMSO With Serum
      • 4.2.2.1. DMSO With Serum Market, 2018 - 2030 (USD Million)
    • 4.2.3. DMSO Without Serum
      • 4.2.3.1. DMSO With Serum Market, 2018 - 2030 (USD Million)
  • 4.3. Glycerol
    • 4.3.1. Glycerol Market, 2018 - 2030 (USD Million)
    • 4.3.2. Glycerol With Serum
      • 4.3.2.1. Glycerol With Serum Market, 2018 - 2030 (USD Million)
    • 4.3.3. Glycerol Without Serum
      • 4.3.3.1. Glycerol With Serum Market, 2018 - 2030 (USD Million)
  • 4.4. Others
    • 4.4.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. Application Business Analysis

  • 5.1. Cell Freezing Media Market: Application Movement Analysis
  • 5.2. Stem Cell Lines
    • 5.2.1. Stem Cell Lines Market, 2018 - 2030 (USD Million)
  • 5.3. Cancer Cell Lines
    • 5.3.1. Cancer Cell Lines Market, 2018 - 2030 (USD Million)
  • 5.4. Others
    • 5.4.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. End-use Business Analysis

  • 6.1. Cell Freezing Media Market: End-Use Movement Analysis
  • 6.2. Pharmaceutical & Biotechnology Companies
    • 6.2.1. Pharmaceutical & Biotechnology Companies Market, 2018 - 2030 (USD Million)
  • 6.3. Academic and Research Institutes
    • 6.3.1. Academic and Research Institutes Market, 2018 - 2030 (USD Million)
  • 6.4. Others
    • 6.4.1. Others Market, 2018 - 2030 (USD Million)

Chapter 7. Regional Business Analysis

  • 7.1. Cell Freezing Media Market Share By Region, 2022 & 2030
  • 7.2. North America
    • 7.2.1. SWOT Analysis
    • 7.2.2. North America Cell Freezing Media Market, 2018 - 2030 (USD Million)
    • 7.2.3. U.S.
      • 7.2.3.1. Key Country Dynamics
      • 7.2.3.2. Target Disease Prevalence
      • 7.2.3.3. Competitive Scenario
      • 7.2.3.4. U.S. Cell Freezing Media Market, 2018 - 2030 (USD Million)
    • 7.2.4. Canada
      • 7.2.4.1. Key Country Dynamics
      • 7.2.4.2. Target Disease Prevalence
      • 7.2.4.3. Competitive Scenario
      • 7.2.4.4. Canada Cell Freezing Media Market, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. SWOT Analysis
    • 7.3.2. Europe Cell Freezing Media Market, 2018 - 2030 (USD Million)
    • 7.3.3. UK
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Target Disease Prevalence
      • 7.3.3.3. Competitive Scenario
      • 7.3.3.4. UK Cell Freezing Media Market, 2018 - 2030 (USD Million)
    • 7.3.4. Germany
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Target Disease Prevalence
      • 7.3.4.3. Competitive Scenario
      • 7.3.4.4. Germany Cell Freezing Media Market, 2018 - 2030 (USD Million)
    • 7.3.5. France
      • 7.3.5.1. Key Country Dynamics
      • 7.3.5.2. Target Disease Prevalence
      • 7.3.5.3. Competitive Scenario
      • 7.3.5.4. France Cell Freezing Media Market, 2018 - 2030 (USD Million)
    • 7.3.6. Italy
      • 7.3.6.1. Key Country Dynamics
      • 7.3.6.2. Target Disease Prevalence
      • 7.3.6.3. Competitive Scenario
      • 7.3.6.4. Italy Cell Freezing Media Market, 2018 - 2030 (USD Million)
    • 7.3.7. Spain
      • 7.3.7.1. Key Country Dynamics
      • 7.3.7.2. Target Disease Prevalence
      • 7.3.7.3. Competitive Scenario
      • 7.3.7.4. Spain Cell Freezing Media Market, 2018 - 2030 (USD Million)
    • 7.3.8. Denmark
      • 7.3.8.1. Key Country Dynamics
      • 7.3.8.2. Target Disease Prevalence
      • 7.3.8.3. Competitive Scenario
      • 7.3.8.4. Denmark Cell Freezing Media Market, 2018 - 2030 (USD Million)
    • 7.3.9. Sweden
      • 7.3.9.1. Key Country Dynamics
      • 7.3.9.2. Target Disease Prevalence
      • 7.3.9.3. Competitive Scenario
      • 7.3.9.4. Sweden Cell Freezing Media Market, 2018 - 2030 (USD Million)
    • 7.3.10. Norway
      • 7.3.10.1. Key Country Dynamics
      • 7.3.10.2. Target Disease Prevalence
      • 7.3.10.3. Competitive Scenario
      • 7.3.10.4. Norway Cell Freezing Media Market, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. SWOT Analysis
    • 7.4.2. Asia Pacific Cell Freezing Media Market, 2018 - 2030 (USD Million)
    • 7.4.3. Japan
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Target Disease Prevalence
      • 7.4.3.3. Competitive Scenario
      • 7.4.3.4. Japan Cell Freezing Media Market, 2018 - 2030 (USD Million)
    • 7.4.4. China
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Target Disease Prevalence
      • 7.4.4.3. Competitive Scenario
      • 7.4.4.4. China Cell Freezing Media Market, 2018 - 2030 (USD Million)
    • 7.4.5. India
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Target Disease Prevalence
      • 7.4.5.3. Competitive Scenario
      • 7.4.5.4. India Cell Freezing Media Market, 2018 - 2030 (USD Million)
    • 7.4.6. Australia
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Target Disease Prevalence
      • 7.4.6.3. Competitive Scenario
      • 7.4.6.4. Australia Cell Freezing Media Market, 2018 - 2030 (USD Million)
    • 7.4.7. Thailand
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Target Disease Prevalence
      • 7.4.7.3. Competitive Scenario
      • 7.4.7.4. Thailand Cell Freezing Media Market, 2018 - 2030 (USD Million)
    • 7.4.8. South Korea
      • 7.4.8.1. Key Country Dynamics
      • 7.4.8.2. Target Disease Prevalence
      • 7.4.8.3. Competitive Scenario
      • 7.4.8.4. South Korea Cell Freezing Media Market, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. SWOT Analysis
    • 7.5.2. Latin America Cell Freezing Media Market, 2018 - 2030 (USD Million)
    • 7.5.3. Brazil
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Target Disease Prevalence
      • 7.5.3.3. Competitive Scenario
      • 7.5.3.4. Brazil Cell Freezing Media Market, 2018 - 2030 (USD Million)
    • 7.5.4. Mexico
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Target Disease Prevalence
      • 7.5.4.3. Competitive Scenario
      • 7.5.4.4. Mexico Cell Freezing Media Market, 2018 - 2030 (USD Million)
    • 7.5.5. Argentina
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Target Disease Prevalence
      • 7.5.5.3. Competitive Scenario
      • 7.5.5.4. Argentina Cell Freezing Media Market, 2018 - 2030 (USD Million)
  • 7.6. MEA
    • 7.6.1. SWOT Analysis
    • 7.6.2. MEA Cell Freezing Media Market, 2018 - 2030 (USD Million)
    • 7.6.3. South Africa
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Target Disease Prevalence
      • 7.6.3.3. Competitive Scenario
      • 7.6.3.4. South Africa Cell Freezing Media Market, 2018 - 2030 (USD Million)
    • 7.6.4. Saudi Arabia
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Target Disease Prevalence
      • 7.6.4.3. Competitive Scenario
      • 7.6.4.4. Saudi Arabia Cell Freezing Media Market, 2018 - 2030 (USD Million)
    • 7.6.5. UAE
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Target Disease Prevalence
      • 7.6.5.3. Competitive Scenario
      • 7.6.5.4. UAE Cell Freezing Media Market, 2018 - 2030 (USD Million)
    • 7.6.6. Kuwait
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Target Disease Prevalence
      • 7.6.6.3. Competitive Scenario
      • 7.6.6.4. Kuwait Cell Freezing Media Market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Share Analysis, 2022
  • 8.4. Company Profiles/Listing
    • 8.4.1. Thermo Fisher Scientific, Inc
      • 8.4.1.1. Overview
      • 8.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. Merck KGaA
      • 8.4.2.1. Overview
      • 8.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. Sartorius AG
      • 8.4.3.1. Overview
      • 8.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Strategic Initiatives
    • 8.4.4. Bio-Life Solutions, Inc.
      • 8.4.4.1. Overview
      • 8.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. Bio-Techne
      • 8.4.5.1. Overview
      • 8.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. HiMedia Laboratories
      • 8.4.6.1. Overview
      • 8.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Strategic Initiatives
    • 8.4.7. PromoCell GmbH
      • 8.4.7.1. Overview
      • 8.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Strategic Initiatives
    • 8.4.8. Capricorn Scientific
      • 8.4.8.1. Overview
      • 8.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Strategic Initiatives
    • 8.4.9. Cell Applications, Inc.
      • 8.4.9.1. Overview
      • 8.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Strategic Initiatives
    • 8.4.10. AMSBIO
      • 8.4.10.1. Overview
      • 8.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Strategic Initiatives